ANRO
Alto Neuroscience·NYSE
--
--(--)
--
--(--)
6.09 / 10
Outperform
Analyst sentiment is bullish with a 100% Strong Buy rating from Chardan Capital, and historical win-rate data supports this view. Fund-flow metrics are strong (7.7/10), with positive Medium and Large inflows, although overall trend is negative. This combination suggests institutional interest persists despite short-term price weakness, potentially providing support for a rebound.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-05
InstitutionChardan Capital
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for ANRO?
- ANRO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.09/10 (Outperform).
